71 related articles for article (PubMed ID: 9225010)
1. In vitro production of antigen-specific T cells from unprimed mice: role of dexamethasone and anti-IL-10 antibodies.
Dozmorov I; Miller RA
Cell Immunol; 1997 Jun; 178(2):187-96. PubMed ID: 9225010
[TBL] [Abstract][Full Text] [Related]
2. Generation of antigen-specific Th2 cells from unprimed mice in vitro: effects of dexamethasone and anti-IL-10 antibody.
Dozmorov IM; Miller RA
J Immunol; 1998 Mar; 160(6):2700-5. PubMed ID: 9510169
[TBL] [Abstract][Full Text] [Related]
3. IL-4 synthesis by in vivo primed keyhole limpet hemocyanin-specific CD4+ T cells. I. Influence of antigen concentration and antigen-presenting cell type.
DeKruyff RH; Fang Y; Umetsu DT
J Immunol; 1992 Dec; 149(11):3468-76. PubMed ID: 1358971
[TBL] [Abstract][Full Text] [Related]
4. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells.
Croft M; Bradley LM; Swain SL
J Immunol; 1994 Mar; 152(6):2675-85. PubMed ID: 7908301
[TBL] [Abstract][Full Text] [Related]
5. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
Mejri N; Brossard M
Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
[TBL] [Abstract][Full Text] [Related]
6. Differential responses of invariant V alpha 24J alpha Q T cells and MHC class II-restricted CD4+ T cells to dexamethasone.
Milner JD; Kent SC; Ashley TA; Wilson SB; Strominger JL; Hafler DA
J Immunol; 1999 Sep; 163(5):2522-9. PubMed ID: 10452989
[TBL] [Abstract][Full Text] [Related]
7. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses.
Gramaglia I; Weinberg AD; Lemon M; Croft M
J Immunol; 1998 Dec; 161(12):6510-7. PubMed ID: 9862675
[TBL] [Abstract][Full Text] [Related]
8. Interferon gamma enhances both in vitro and in vivo priming of CD4+ T cells for IL-4 production.
Bocek P; Foucras G; Paul WE
J Exp Med; 2004 Jun; 199(12):1619-30. PubMed ID: 15210741
[TBL] [Abstract][Full Text] [Related]
9. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
[TBL] [Abstract][Full Text] [Related]
10. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
Margenthaler JA; Flye MW
J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
[TBL] [Abstract][Full Text] [Related]
11. Modulation of naive CD4 T cell activation with altered peptide ligands: the nature of the peptide and presentation in the context of costimulation are critical for a sustained response.
Rogers PR; Grey HM; Croft M
J Immunol; 1998 Apr; 160(8):3698-704. PubMed ID: 9558070
[TBL] [Abstract][Full Text] [Related]
12. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells.
Nishimura E; Sakihama T; Setoguchi R; Tanaka K; Sakaguchi S
Int Immunol; 2004 Aug; 16(8):1189-201. PubMed ID: 15237110
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo inhibition of activation induced T cell apoptosis by bucillamine.
Okazaki H; Sato H; Kamimura T; Hirata D; Iwamoto M; Yoshio T; Mimori A; Masuyama JI; Kano S; Minota S
J Rheumatol; 2000 Jun; 27(6):1358-64. PubMed ID: 10852254
[TBL] [Abstract][Full Text] [Related]
14. Induction of tolerance by IL-10-treated dendritic cells.
Steinbrink K; Wölfl M; Jonuleit H; Knop J; Enk AH
J Immunol; 1997 Nov; 159(10):4772-80. PubMed ID: 9366401
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
16. Availability of antigen-presenting cells can determine the extent of CD4 effector expansion and priming for secretion of Th2 cytokines in vivo.
Bradley LM; Harbertson J; Biederman E; Zhang Y; Bradley SM; Linton PJ
Eur J Immunol; 2002 Aug; 32(8):2338-46. PubMed ID: 12209647
[TBL] [Abstract][Full Text] [Related]
17. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
[TBL] [Abstract][Full Text] [Related]
18. Antigen-primed T cells from B cell-deficient JHD mice fail to provide B cell help.
Macaulay AE; DeKruyff RH; Umetsu DT
J Immunol; 1998 Feb; 160(4):1694-700. PubMed ID: 9469426
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting IL-12 production.
DeKruyff RH; Fang Y; Umetsu DT
J Immunol; 1998 Mar; 160(5):2231-7. PubMed ID: 9498762
[TBL] [Abstract][Full Text] [Related]
20. High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro.
George TC; Bilsborough J; Viney JL; Norment AM
Eur J Immunol; 2003 Feb; 33(2):502-11. PubMed ID: 12645949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
